BiDil, a new tablet containing isosorbide dinitrate and hydralazine for treating heart failure in blacks

August 2005

You'll soon see BiDil, a new tablet containing isosorbide dinitrate and hydralazine for treating heart failure in blacks.

It's the first drug approved for a specific race.

BiDil improves survival when ADDED to standard therapy... ACE inhibitors, beta-blockers, diuretics, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote